Insulin, Globin Zinc [clinicaltrials_resource:cfe6e68d4b07bb03d3e7b7e9860f0023]
clinicaltrials:NCT00000620Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism [clinicaltrials:NCT00004825]clinicaltrials:NCT00006305clinicaltrials:NCT00032487clinicaltrials:NCT00035815Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin [clinicaltrials:NCT00036504]Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents [clinicaltrials:NCT00046501]Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus. [clinicaltrials:NCT00063128]Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes [clinicaltrials:NCT00065130]clinicaltrials:NCT00069784Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population [clinicaltrials:NCT00071448]clinicaltrials:NCT00082381clinicaltrials:NCT00082407Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes [clinicaltrials:NCT00095082]Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents [clinicaltrials:NCT00097071]Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes [clinicaltrials:NCT00097084]clinicaltrials:NCT00097500Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes [clinicaltrials:NCT00097877]Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents [clinicaltrials:NCT00099333]Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy [clinicaltrials:NCT00099619]Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes [clinicaltrials:NCT00104182]Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes [clinicaltrials:NCT00106366]Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients [clinicaltrials:NCT00107601]Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents [clinicaltrials:NCT00115570]Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes [clinicaltrials:NCT00117780]South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus [clinicaltrials:NCT00121966]clinicaltrials:NCT00127634Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin [clinicaltrials:NCT00135057]Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus [clinicaltrials:NCT00135083]Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin [clinicaltrials:NCT00135096]Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) [clinicaltrials:NCT00135941]clinicaltrials:NCT00136916clinicaltrials:NCT00137046Insulin on Post Burn Hypermetabolism [clinicaltrials:NCT00137254]clinicaltrials:NCT00138671clinicaltrials:NCT00139659clinicaltrials:NCT00143247Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose [clinicaltrials:NCT00145353]clinicaltrials:NCT00147745Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients [clinicaltrials:NCT00147836]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Insulin, Globin Zinc [clinicaltrials_resource:cfe6e68d4b07bb03d3e7b7e9860f0023]
Bio2RDF identifier
cfe6e68d4b07bb03d3e7b7e9860f0023
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cfe6e68d4b07bb03d3e7b7e9860f0023
identifier
clinicaltrials_resource:cfe6e68d4b07bb03d3e7b7e9860f0023
title
Insulin, Globin Zinc
@en
type
label
Insulin, Globin Zinc [clinicaltrials_resource:cfe6e68d4b07bb03d3e7b7e9860f0023]
@en